Owner Bolder Biotechnology, Inc.

Inventors Cox, George N; Doherty, Daniel H; Rosendahl, Mary S

Agent Freehills

Pub. Number AU-B-2008202371

Parent 2004231217

Filing date 29 May 2008

Wipo publication date 19 June 2008

Acceptance publication date 2 August 2012

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/04 Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/21 Medicinal preparations containing peptides - Interferons

A61K 38/22 Medicinal preparations containing peptides - Hormones

A61K 38/27 Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 5/02 Drugs for disorders of the endocrine system

A61P 7/06 Drugs for disorders of the blood or the extracellular fluid

A61P 43/00 Drugs for specific purposes, not provided for in groups

C07K 14/47 Peptides having more than 20 amino acids

C07K 14/505 Peptides having more than 20 amino acids

C07K 14/56 Peptides having more than 20 amino acids

C07K 14/575 Peptides having more than 20 amino acids

C07K 14/61 Peptides having more than 20 amino acids

C07K 14/72 Peptides having more than 20 amino acids

C12P 21/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12R 1/19